Microarray analysis indicates that TRIM29 is overexpressed in the lung, pancreatic, gastric, bladder, colorectal, ovarian, and endometrial cancers, as well as plasma cell myeloma27–32. This evidence concerns the gene TRIM29 and endometrial cancer.